Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy.
Cancer biology & therapy | 2014-03-01 | PMID 24351336
Gamerith Gabriele, Auer Thomas, Amann Arno and 6 more
Genes: KRAS, APC, EGFR
